Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 993 across all filing types
Latest filing 2024-04-23 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
独立董事提名人声明与承诺（倪崖）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by the nominating party (the company's board) regarding the nomination of an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There is no financial data, no discussion of financial results, no mention of shareholder voting results, or any other financial or operational report content. The document is clearly related to board/management information, specifically the nomination of a board member. Therefore, the most appropriate classification is 'Board/Management Information' (MANG). The document length (5323 characters) supports it being a full statement rather than a brief announcement or notice.
2024-04-23 Chinese
独立董事提名人声明与承诺（董明）
Board/Management Information Classification · 100% confidence The document is a formal statement and commitment by the nominating party regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with laws and regulations, and independence criteria for the nominee. There is no financial data, no report of financial performance, no voting results, no meeting materials, and no mention of a report publication. The content is focused on board/management information specifically about the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is over 5,000 characters and contains detailed statements, not just an announcement or certification, so it is not RNS or RPA.
2024-04-23 Chinese
独立董事候选人声明与承诺（倪崖）
Regulatory Filings Classification · 95% confidence The document is a formal declaration and commitment statement by a candidate for an independent director position at Zhejiang Tailin Biotechnology Co., Ltd. It details the candidate's qualifications, compliance with relevant laws and regulations, and commitments related to the role of an independent director. There is no financial data, no report of financial results, no announcement of voting results, no management or board changes, and no mention of any meeting or shareholder vote. The document is a regulatory compliance statement related to corporate governance and director qualifications, but it is not a governance report itself nor a proxy solicitation. It is a regulatory filing related to director candidacy disclosures and compliance with securities exchange rules. Therefore, the best fitting category is Regulatory Filings (RNS).
2024-04-23 Chinese
独立董事2023年度述职报告（杨忠智）
Board/Management Information Classification · 95% confidence The document is a detailed annual performance report of an independent director of Zhejiang Tailin Biotechnology Co., Ltd. for the year 2023. It includes the director's personal background, attendance at board and shareholder meetings, committee work, independent opinions, communication with auditors, oversight of related party transactions, and other governance activities. The content focuses on the director's duties, governance, and compliance with laws and regulations, rather than financial results or audit opinions. It is not a financial report, audit report, or earnings release. It is a management/governance-related report specifically from an independent director about their annual duties and observations. This fits best under Board/Management Information (MANG), which covers announcements related to board or senior management changes or reports. The document is not a proxy statement, remuneration report, or regulatory filing. Therefore, the classification is MANG with high confidence.
2024-04-23 Chinese
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding the election of the supervisory board members (监事会换届选举). It details the nomination of candidates for the supervisory board, their qualifications, and the process for election at the shareholders' meeting. There is no financial data, no mention of financial results, no audit information, or other report types. The content is about changes in the supervisory board, which is part of the company's governance and management structure. Therefore, this fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2024-04-23 Chinese
2023年年度报告
Annual Report Classification · 100% confidence The document is titled '2023 年年度报告' which translates to '2023 Annual Report'. It contains detailed sections including company overview, financial data, management discussion and analysis, governance, environmental and social responsibility, important matters, shareholder information, bond information, and financial statements. The document includes comprehensive financial figures, management commentary, and audit information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of detailed financial data and management analysis confirms it is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-04-23 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.